Entrada Therapeutics, Inc.TRDANASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank67
3Y CAGR+26.0%
5Y CAGR+18.3%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+26.0%/yr
Annual compound
5Y CAGR
+18.3%/yr
Recent acceleration
Percentile
P67
Within normal range
vs 5Y Ago
2.3x
Strong expansion
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $90.39M | -10.7% |
| 2024 | $101.21M | +49.7% |
| 2023 | $67.60M | +49.7% |
| 2022 | $45.16M | -84.5% |
| 2021 | $291.06M | +645.5% |
| 2020 | $39.05M | +131.8% |
| 2019 | $16.84M | - |